Opportunistic Infections: Clinical Trials

26 trials for Opportunistic Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 3 terminated, 1 unknown. 26 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 326Completed 22, Terminated 3, Unknown 1
Phase 21Completed 1

Follow Opportunistic Infections: new trials by email Literature Review of Opportunistic Infections trials Research Report on Opportunistic Infections

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cryptococcal Antigen Screening Plus Sertraline
Sertraline, Placebo Oral Tablet, Fluconazole - Cryptococcosis, Cryptococcal Infections
Phase 3TerminatedUniversity of Minnesota222017-11-152020-06-09
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
CD45RA-depleted peripheral blood mononuclear cells - Leukemia, Lymphoma
Phase 2 / Phase 3CompletedFederal Research Institute of Pediatric Hematology, Oncology and Immunology1502016-10-012023-03-16
A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients
Early versus intermediate versus late initiation of ART - HIV Infections, Tuberculosis
Phase 3CompletedCentre for the AIDS Programme of Research in South Africa6422005-06-012011-03-24
Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
Everolimus, Mycophenolatmofetil - Lung Transplantation
Phase 3CompletedHannover Medical School1902005-03-012011-12-08
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
Nitazoxanide - Cryptosporidiosis, HIV Infections
Phase 3TerminatedRomark Laboratories L.C.302000-02-012005-06-24
Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
Posaconazole, Fluconazole - Candidiasis, Oral, HIV Infections
Phase 3CompletedSchering-Plough3001998-08-012005-06-24
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
Albendazole - Protozoan Infections, HIV Infections
Phase 3CompletedSmithKline Beecham2005-06-24
Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
Lamivudine/Zidovudine, Nelfinavir mesylate, Efavirenz - HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2502011-03-02
Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
Trimetrexate glucuronate, Sulfamethoxazole-Trimethoprim, Leucovorin calcium - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3022021-11-04
A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2008-09-30
A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Aldesleukin - HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)4602021-10-29
A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS
Pentamidine isethionate, Sulfamethoxazole-Trimethoprim - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2402021-11-03
A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002
Zidovudine, Zalcitabine - HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1202021-11-03
A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
Pentamidine isethionate, Sulfamethoxazole-Trimethoprim, Dapsone - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)6002021-11-04
A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
Globulin, Immune, Zidovudine - HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2502021-11-03
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
Valganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 3UnknownHoffmann-La Roche5002005-06-24
A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)
Pentamidine isethionate, Pyrimethamine, Sulfamethoxazole/Trimethoprim - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3222021-11-03
A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
Zidovudine - HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2402021-11-04
An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies
Trimetrexate glucuronate, Leucovorin calcium - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2021-10-29
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
IM862 - Sarcoma, Kaposi, HIV Infections
Phase 3CompletedCytran2002005-06-24

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

AIDS-Related Opportunistic Infections (23)  ·  HIV Infections (23)  ·  Acquired Immunodeficiency Syndrome (15)  ·  Pneumonia, Pneumocystis (9)  ·  Cytomegalovirus Retinitis (3)  ·  AIDS-Related Complex (2)  ·  Cryptococcosis (2)  ·  Cytomegalovirus Infections (2)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (2)  ·  Respiratory Aspiration (2)  ·  Retinitis (2)  ·  Sarcoma, Kaposi (2)  ·  Tuberculosis (2)  ·  Adolescent Behavior (1)

Broader conditions

Infections (26)  ·  Immune System Diseases (25)  ·  Blood-Borne Infections (24)  ·  Communicable Diseases (24)  ·  Immunologic Deficiency Syndromes (24)  ·  Lentivirus Infections (24)  ·  RNA Virus Infections (24)  ·  Retroviridae Infections (24)  ·  Virus Diseases (24)  ·  Genital Diseases (23)  ·  Sexually Transmitted Diseases (23)  ·  Sexually Transmitted Diseases, Viral (23)  ·  Urogenital Diseases (23)  ·  Bacterial Infections and Mycoses (15)

Interventions

Zidovudine (7)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (6)  ·  Pentamidine (5)  ·  Leucovorin (4)  ·  trimetrexate glucuronate (4)  ·  Fluconazole (3)  ·  Ganciclovir (2)  ·  Albendazole (1)  ·  Amphotericin B (1)  ·  Dapsone (1)  ·  Ethambutol (1)  ·  Everolimus (1)  ·  Immunoglobulins (1)  ·  Isoniazid (1)  ·  Lamivudine (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (15)  ·  Schering-Plough (2)  ·  Centre for the AIDS Programme of Research in South Africa (1)  ·  Cytran (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Hannover Medical School (1)  ·  Hoffmann-La Roche (1)  ·  Pfizer (1)  ·  Romark Laboratories L.C. (1)  ·  SmithKline Beecham (1)  ·  University of Minnesota (1)

Countries

United States (22)  ·  Puerto Rico (2)  ·  Australia (1)  ·  Barbados (1)  ·  Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  Russia (1)  ·  South Africa (1)  ·  Tanzania (1)  ·  Uganda (1)

Top investigators

Feinberg J (2)  ·  Fischl M (2)  ·  Sattler FR (2)  ·  Ariela Noy (1)  ·  Armstrong D (1)  ·  B Montgomery (1)  ·  David Scadden (1)  ·  Denis Jones (1)  ·  Diane Havlir (1)  ·  Dismukes W (1)  ·  Donald I. Abrams (1)  ·  El-Sadr W (1)  ·  Elizabeth K Nalintya, MBChB MPH (1)  ·  Hardy WD (1)  ·  Holzman R (1)

Results publications

PMID 20181971, PMID 22010915, PMID 22944873, PMID 32415846

NIH funding

U01AI125003 (1)